Certain ACE inhibitors and calcium channel blockers improve insulin sensitivity in animal models of hypertension and diabetes, whereas others do not, highlighting differential metabolic effects of antihypertensive agents.
No takes yet. Share an insight, caveat, or question.
Should not yet change antihypertensive selection in diabetes; hypothesis-generating for differential insulin-sensitivity effects requiring human trials.
Ramesh K. Goyal (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: